Exploring Public Perceptions of Vaccine-Derived Poliovirus and a Novel Oral Polio Vaccine in the Democratic Republic of the Congo, Kenya, and Nigeria
"Scientifically-informed decisions intended to benefit the community may not be well-received by communities if they are not supported by adequate communications interventions." In November 2020, the Global Polio Eradication Initiative (GPEI) introduced novel oral polio vaccine Type 2 (nOPV2) to address circulating vaccine-derived poliovirus Type 2
Source: comminit.com